Pharma Vietnam’s clinical engagement landscape reached a national milestone on July 25, 2026, when Vinphaco participated in the Vietnam Respiratory Society’s Annual Scientific Conference at Crowne Plaza Da Nang — the country’s most authoritative specialist forum in respiratory medicine, bringing together thousands of healthcare professionals nationwide alongside leading Vietnamese and international respiratory medicine experts. Vinphaco attended as both conference partner and active clinical exhibitor, sponsoring 49 respiratory medicine delegates and operating a dedicated exhibition booth for direct clinical exchange. For further context on Vinphaco’s Vietnamese operations, visit vinphaco.vn.

Vietnam Respiratory Society Annual Conference — The Highest Clinical Authority in the Specialty

 

The Vietnam Respiratory Society’s Annual Scientific Conference is the premier national forum for respiratory medicine in Vietnam — where pulmonologists, intensivists, internal medicine specialists, and clinical pharmacists from every tier of the national healthcare system converge annually to update clinical knowledge on the diagnosis, screening, and treatment of respiratory conditions including COPD, bronchial asthma, respiratory infections, and rare lung diseases.

For a pharma Vietnam manufacturer whose active ingredient portfolio includes bronchodilators, corticosteroids, antibiotics, and respiratory support formulations, this is the single most significant annual gathering of the clinical community that prescribes and evaluates those products. Vinphaco’s presence at this conference is not incidental — it is a strategic engagement with the highest-authority clinical validation environment available in its core therapeutic area.

49 Sponsored Delegates — Investing in Clinical Knowledge at Scale

Vinphaco sponsored the attendance of 49 respiratory medicine healthcare professionals at the full scientific program — enabling direct access to the latest international and domestic clinical evidence on respiratory disease management from leading experts in the field.

For international pharmaceutical buyers assessing a pharma Vietnam contract manufacturing partner, delegate sponsorship of this scale at a national specialist conference signals that the manufacturer’s clinical engagement is substantive, not superficial. A company that invests in the scientific education of 49 specialist clinicians at the country’s top respiratory conference is one whose product quality claims are being continuously tested in the most rigorous clinical peer environment available, demonstrating a long-term commitment to advancing medical standards while fostering transparent professional dialogue across healthcare networks.

Exhibition Presence — Clinical Dialogue on Treatment Solutions

At Vinphaco’s conference exhibition booth, substantial numbers of attending healthcare professionals engaged in direct discussion of respiratory treatment approaches — focusing on therapeutic efficacy, safety profiles, and cost-effectiveness considerations that define real-world clinical decision-making in Vietnam’s healthcare system.

This clinical dialogue is one of the most valuable quality feedback mechanisms available to a pharmaceutical manufacturer. Prescribers who engage directly with a manufacturer’s medical affairs team at a national specialist conference are providing real-time clinical intelligence — on treatment outcomes, on formulary considerations, and on the practical requirements that pharmaceutical products must meet to be genuinely useful in patient care. Vinphaco listens to this intelligence and integrates it into its manufacturing and product development priorities

A Year-Long Clinical Engagement — Now at National Scale

The Da Nang conference represents the largest-scale single engagement in Vinphaco’s 2026 respiratory medicine clinical partnership program — which has now spanned the Vinphaco Speaker Tour in Bac Ninh, the national respiratory conference in Can Tho, and the Dong Thap pediatric respiratory session, culminating in the Vietnam Respiratory Society’s national annual conference with thousands of attendees.

Across 2026, Vinphaco has directly engaged with over one thousand healthcare professionals in respiratory and related specialties — through sponsored attendance, exhibition presence, and specialist-led educational programs distributed across northern, central, and southern Vietnam simultaneously. For international partners, this sustained, nationally distributed, multi-format clinical engagement program is the clearest available evidence that Vinphaco’s pharma Vietnam positioning is backed by genuine clinical system integration, not marketing expenditure alone.

To discuss pharmaceutical contract manufacturing, respiratory medicine active ingredient supply, or international distribution partnerships: vinphaco.net/contact | vinphaco.vn